У нас вы можете посмотреть бесплатно Targeting Aging Ep4 - Path To Longevity Drugs Approval | Professor Matt Kaeberlein Interview Series или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Professor Kaeberlein talks about what the path would be to get rapamycin or similar drugs approved for use as longevity drugs rather than for specific conditions. Dr. Matt Kaeberlein is a Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington. His research interests are focused on basic mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life. He is currently leading The Dog Aging project, a large multi-year trial to study the aging of companion dogs in a normal environment. He has published nearly 200 papers in top scientific journals and has been recognized by several prestigious awards, including a Breakthroughs in Gerontology Award, and most recent GSA’s 2020 Robert W. Kleemeier Award Professor Kaeberlein at University of Washington https://depts.washington.edu/mbwc/abo... Dog Aging Project. https://dogagingproject.zendesk.com/h... #Rapamycin #DogAgingProject #Longegvity